David Seiffge Selected Research

David Seiffge Research Topics

Disease

18	Stroke (Strokes) 01/2024 - 05/2015
15	Ischemic Stroke 04/2024 - 10/2020
5	Hemorrhage 04/2024 - 01/2018
5	Cerebral Hemorrhage 03/2024 - 01/2016
5	Transient Ischemic Attack 12/2023 - 01/2022
4	Atrial Fibrillation 12/2023 - 08/2021
4	Neoplasms (Cancer) 01/2023 - 07/2022
3	Infarction (Infarctions) 03/2024 - 07/2010
3	Hematoma 03/2024 - 09/2022
2	Blood Vessel Dissection 02/2024 - 01/2021
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 01/2023
2	Cerebral Small Vessel Diseases 09/2022 - 01/2022
1	Traumatic Cerebral Hemorrhage 03/2024
1	Ischemia 02/2024
1	Hypertension (High Blood Pressure) 12/2023
1	Coronary Disease (Coronary Heart Disease) 12/2023
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2023
1	Diabetes Mellitus 01/2023
1	Embolism (Embolus) 01/2023
1	Siderosis 01/2023
1	Atherosclerosis 01/2023
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 09/2022
1	Brain Ischemia (Cerebral Ischemia) 09/2022
1	Embolic Stroke 08/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Epilepsy (Aura) 08/2021
1	Wounds and Injuries (Trauma) 01/2018
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 05/2015
1	Pathologic Constriction (Stenosis) 05/2015
1	Cerebral Infarction 07/2010

Drug/Important Bio-Agent (IBA)

10	AnticoagulantsIBA 02/2024 - 08/2021
7	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2022
4	Warfarin (Coumadin)FDA LinkGeneric 10/2023 - 01/2021
4	Vitamin K FDA Link 10/2023 - 01/2021
3	fibrin fragment D (D-dimer)IBA 01/2023 - 01/2022
2	PRT064445IBA 03/2024 - 10/2023
2	Factor Xa InhibitorsIBA 03/2024 - 10/2023
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2024 - 01/2021
2	A-factor (Streptomyces)IBA 10/2023 - 07/2010
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 01/2023
2	C-Reactive ProteinIBA 09/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 05/2015
2	Tranexamic Acid (AMCA)FDA Link 01/2018 - 01/2016
1	thiamine triphosphorate (TTP)IBA 03/2024
1	N(4)-methyl-2'-deoxycytidine 5'-triphosphateIBA 03/2024
1	N(4)-oleylcytosine arabinosideIBA 03/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023
1	LipidsIBA 12/2023
1	RivaroxabanIBA 10/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 10/2023
1	Factor IIaIBA 10/2023
1	AntidotesIBA 10/2023
1	apixabanIBA 10/2023
1	Prothrombin (Factor II)IBA 10/2023
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2023
1	APTIBA 01/2023
1	Oral ContraceptivesIBA 01/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	Apolipoproteins E (ApoE)IBA 09/2022
1	CreatinineIBA 07/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	TroponinIBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	Dabigatran FDA Link 01/2022
1	Phenprocoumon (Liquamar)FDA Link 01/2021
1	AcenocoumarolIBA 01/2021
1	SodiumIBA 07/2010
1	ChlorineIBA 07/2010
1	Protons (Proton)IBA 07/2010

Therapy/Procedure

11	Therapeutics 04/2024 - 08/2021
8	Thrombectomy 01/2024 - 10/2020
2	Secondary Prevention 01/2023 - 01/2023
1	Treatment Delay 02/2024
1	Conservative Treatment 02/2024
1	Time-to-Treatment 01/2024
1	Glycemic Control 01/2023
1	Neurological Rehabilitation 08/2021